样式: 排序: IF: - GO 导出 标记为已读
-
Use of complementary and alternative medicine in vitiligo: a cross-sectional survey Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-04-23 Sneha Poondru, Lynna J. Yang, Roopal V. Kundu
Vitiligo is characterized by skin depigmentation, which can lead to profound psychological effects and decreased quality of life, especially for those with skin of color. Individuals with vitiligo may utilize complementary and alternative medicine (CAM) due to limited treatment options with varying efficacy. An anonymous, multiple-choice, cross-sectional questionnaire was distributed to participants
-
Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-04-18 Alice J. Tan, Marjorie Archila, John S. Barbieri, Arash Mostaghimi, Aaron M. Scherer, Lourdes M. Perez-Chada, Maryam M. Asgari, Joel M. Gelfand, Megan H. Noe
Patients with autoimmune bullous diseases are at an increased risk of infection, both from the underlying skin disease and from immunosuppressive treatments. Limited information is available on vaccine beliefs and behaviors in dermatology patients and adults with autoimmune bullous diseases in particular. To understand vaccine decision making, identify perceived risks and benefits of vaccinations,
-
Efficacy and safety of botulinum toxin in treating scleroderma-associated raynaud’s phenomenon: a systematic review and meta-analysis Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-04-17 Amr Elrosasy, Mohamed Abo Zeid, Shirin cadri, Belal M. Fahmy, Mohamed A. Elzeftawy, Fatma Mohammed, Alaa Ramadan
-
The role of thymic stromal lymphopoietin in cutaneous disorders Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-04-17 Alexander J. Jafari, Melissa Rivera, Adelaide A. Hebert
-
The role of teledermatology in Mohs micrographic surgery: a review Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-04-16 Yanci A. Algarin, Dana Jaalouk, Anika Pulumati, Keyvan Nouri
This paper explores the role of teledermatology (TD) in Mohs micrographic surgery (MMS) at various stages of patient care. The study aims to assess the benefits, limitations, and patient experiences surrounding TD integration into MMS practices. We conducted a PubMed search using keywords related to TD and MMS, categorizing selected articles into pre-operative, intra-operative, and post-operative stages
-
Sentinel lymph node biopsy versus observation in high risk cutaneous squamous cell carcinoma of head and neck: a propensity score matching analysis Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-04-16 Wenqi Zhang, Qigen Fang, Xu Zhang, Liyuan Dai, Ruihua Luo, Junhui Yuan
-
Association between miR-202, miR-211, and miR-1238 gene polymorphisms and risk of vitiligo Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-04-10 Mahdieh Jafari Shahroudi, Mahnaz Rezaei, Mehdi Mirzaeipour, Mohsen Saravani, Hossein Shahraki-Ghadimi, Sara Arab
Vitiligo, as a common pigment defect in the skin, hair, and mucous membranes, results from the destruction of melanocytes. Recent investigations have shown that miRNA dysregulation contributes in the pathogenesis of vitiligo. Therefore, in this research, our aim is to explore the relationship between miR-202 rs12355840, miR-211 rs8039189, and miR-1238 rs12973308 polymorphisms and susceptibility to
-
Characterization of alopecia clinical trials: an analysis of trials registered on clinicaltrials.gov Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-04-01 Hailey Konisky, Eliza Balazic, Kseniya Kobets
-
Skin color reporting in squamous cell carcinoma-related randomized controlled trials in top dermatology journals: a systematic review Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-30 Natasha L. Salmen, Klarens Menage, Anthony N. Baumann, Deven P. Curtis, Robert T. Brodell
The objectives are to determine the frequency that skin color is reported in randomized controlled trials (RCTs) involving squamous cell carcinoma (SCC) detection and treatment in leading dermatology journals. A systematic review of RCTs involving SCC was conducted among the top ten most impactful dermatology journals from inception to July 10th, 2023. Studies were included if they reviewed the treatment
-
Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030 Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-26 Kaijie Wang, Yuting Zhao, Xianwei Cao
-
Optimizing intralesional triamcinolone acetonide treatment for isolated nail psoriasis: a pilot, intra-subject randomized controlled trial Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-25 Jose W. Ricardo, Yuqing Qiu, Shari R. Lipner
-
Selinexor targets expression of metabolic genes in Merkel cell carcinoma cells Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-23 Stephen A. Moore, Jennifer R. Landes, Rebecca A. Simonette, Qin He, Hung Q. Doan, Peter L. Rady, Stephen K. Tyring
-
Validation of the Investigator Global Assessment of Chronic Hand Eczema (IGA–CHE): a new clinician reported outcome measure of CHE severity Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-20 Jonathan I. Silverberg, Tove Agner, Keith Baranowski, Ursula Plohberger, Henrik Thoning, Rob Arbuckle, Laura Grant, George Skingley, Robert Bissonnette
-
Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-18 Paras Patel, Jennifer Wang, David Bitterman, Jessica Mineroff, Evan Austin, Jared Jagdeo
-
Circulating biomarkers of oxidative stress in people with acne vulgaris: a systematic review and meta-analysis Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-15 Liang Su, Fang Wang, Yuan Wang, Cheng Qin, Xuesong Yang, Jianzhou Ye
-
Surgical margins and outcomes for eyelid melanoma: a systematic review and meta-analysis Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-15 Catherine E. Pisano, Megan H. Trager, Weijia Fan, Faramarz H. Samie
-
Topical steroids or emollients: does order matter? Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-15 Kripa Ahuja, Peter A. Lio
-
Herpes zoster infection in pregnancy: features and consequences Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-15
Abstract Herpes (varicella) zoster (HZ) infection occurs in 4 people per 1000 in the general US population (irrespective of prior varicella infection and vaccination status) each year and has been the subject of scientific inquiry for decades. The consequences of infection are myriad and may depend on the dermatome of involvement as well as host factors such as age, comorbidities, prior treatment or
-
Cracking the code: unveiling the nexus between atopic dermatitis and addictive behavior: a cross-sectional exploration of risk factors Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-14 Antonia Mick, Hannah Wecker, Stefanie Ziehfreund, Julia-Tatjana Maul, Tilo Biedermann, Alexander Zink
-
The United States dermatology inpatient workforce between 2013 and 2019: a Medicare analysis reveals contraction of the workforce and vast access deserts—a cross-sectional analysis Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-14
Abstract While time spent practicing inpatient dermatology has decreased since the 1990s, less is known about the current state of inpatient dermatology. We describe the distribution and frequency of inpatient dermatology encounters servicing the United States Medicare population between 2013 and 2019. Cross-sectional analysis of publicly available inpatient Medicare Part B claims data from 2013 to
-
Using probiotics to treat acne vulgaris: systematic review Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-12 Aleena Boby, Grace Lee, Nicole Natarelli, Lilia Correa
-
More yeast, more problems?: reevaluating the role of Malassezia in seborrheic dermatitis Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-12
Abstract Seborrheic dermatitis (SD) is an inflammatory skin disorder and eczema subtype increasingly recognized to be associated with significant physical, psychosocial, and financial burden. The full spectrum of SD, including dandruff localized to the scalp, is estimated to affect half of the world’s population. Despite such high prevalence, the exact etiopathogenesis of SD remains unclear. Historically
-
Review of the application of the most current sophisticated image processing methods for the skin cancer diagnostics purposes Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-06 Maria Myslicka, Aleksandra Kawala-Sterniuk, Anna Bryniarska, Adam Sudol, Michal Podpora, Rafal Gasz, Radek Martinek, Radana Kahankova Vilimkova, Dominik Vilimek, Mariusz Pelc, Dariusz Mikolajewski
-
Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-06
Abstract Peristomal pyoderma gangrenosum is an uncommon subtype of pyoderma gangrenosum mainly affecting stoma sites of patients with inflammatory bowel disease. While surgical treatments are often used to assist healing, little is known about the relationship between surgical interventions and the rate of recurrence of peristomal pyoderma gangrenosum. The aim of this study was to identify patient
-
Assessment of PD-1 and PD-L1 tissue expression levels in lichen planus patients: a case–control study Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-02
Abstract Programmed cell death protein-1 (PD-1) is an immune checkpoint protein, PD-1 interaction with PD ligand-1 (PD-L1) is essential for maintaining immunological tolerance. The study aimed to study and compare the levels of PD-1 and PD-L1 in lesional and nonlesional skin of lichen planus (LP) patients and compare these levels to normal healthy controls to assess their role in the pathogenesis of
-
Live vaccinations in dermatology for immunosuppressed patients: a narrative review Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-02 Divya M. Shan, Rithi J. Chandy, Andrew Fultz, John W. Sanders, Steven R. Feldman
Given the higher susceptibility to infectious disease in patients receiving immunosuppressive therapies for inflammatory dermatologic conditions, immunization is important in this population. While live vaccines protect against life-threatening diseases, they can be harmful in immunosuppressed patients given the risk of replication of the attenuated pathogen and adverse reactions. The utilization of
-
Characterizing differences in outpatient dermatologic care utilization among disaggregated Asian American subgroups Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-03-01 Kanika Kamal, Priya Manjaly, Sophia Ly, Guohai Zhou, Nicholas Theodosakis, Arash Mostaghimi
Despite having significantly higher rates of atopic dermatitis, psoriasis, and pigmentary disorders compared to White patients, studies suggest that Asian Americans are underrepresented in outpatient dermatology clinics. In this study, we utilize the National Health Interview Survey (NHIS) and prioritize disaggregated analyses to evaluate differences between the most populous Asian American subgroups
-
The potential cutaneous benefits of edible bird’s nest Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-02-24 Jennifer Wang, Paras Patel, Jessica Mineroff, Jared Jagdeo
Edible bird’s nest (EBN) is composed of the solidified saliva of swiftlet birds. EBN has been extremely popular in Asian culture for centuries. They are often consumed as a delicacy in the form of bird’s nest soup and are believed to have numerous skin benefits. In light of EBN’s growing popularity and significant cultural importance, we aim provide a comprehensive review of EBN’s potential dermatologic
-
Patient perspectives on topical minoxidil for hair loss: a survey-based study from the University of Michigan Alopecia Clinic Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-02-24 Olivia Lamberg, Sarah Abdel-Mageed, Eric Olsen, Giselle Guerrero, Yolanda R. Helfrich, Julie E. Mervak
Topical minoxidil is a widely used therapy for alopecia. Its availability over the counter in the United States makes it easily accessible. Various factors impact whether an individual decides to pursue treatment and/or continue long-term use. Our study aimed to investigate patient awareness, opinions, and hesitations regarding topical minoxidil use for hair loss treatment. The study also aimed to
-
Mycobacterial tissue culture positivity in the work-up of suspected cutaneous infection in a rural dermatology patient population Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-02-22 Britt K. DeRuyter, Hannah B. Fleischmann, Erik J. Stratman
Dermatologists may be over-ordering mycobacterial tissue cultures when performing the broad work-up of skin infection. The objective of this study was to determine mycobacterial tissue culture positivity in the work-up of suspected skin infection. This was a retrospective cohort study including patients biopsied for mycobacterial tissue cultures performed by dermatology providers from 2006 to 2020
-
High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care regionalization Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-02-13 Shayan Cheraghlou, Vartan Pahalyants, Neil K. Jairath, Nicole A. Doudican, John A. Carucci
-
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysis Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-02-08
Abstract Psoriasis is a chronic, inflammatory skin disorder characterized by well-demarcated erythematous lesions with surface scaling. The disease is underpinned by a dysregulated immune response with a shift in the balance of neutrophils, lymphocytes and platelets. We sought to evaluate the novel systemic inflammatory markers, neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio
-
Why different types of patients seek cosmetic treatments Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-02-07
Abstract The extent to which demographics drive patients to pursue minimally invasive cosmetic procedures is not well-understood. The aim of this project was to better understand how patient demographics impact motivations for cosmetic procedures, irrespective of the procedure desired. Patient-level information from the Cosmetic Motivation Database was evaluated using linear regression analyses to
-
Effects of systemic treatment on the risk for cardiovascular diseases in psoriasis: a nationwide population-based study in South Korea Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-25 Yeon Seok Lee, Yu Jin Lee, Jung Min Lee, June Hyunkyung Lee, Tae Young Han, Jae Eun Choi
-
Female patient perspective on the incorporation of genital skin examination during routine total body skin exams Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-23 Michelle Dellalana, Vijay Kodumudi, Kristin Torre, Ndidi Enwereji, Marti Rothe, Hao Feng
-
Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case–control study in the All of Us Research Program Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-22 Kanika Kamal, David H. Xiang, Katherine Young, Arash Mostaghimi, John S. Barbieri, Jeffrey M. Cohen, Nicholas Theodosakis
Dermatologic diseases have a well-documented association with depression and anxiety, which are in turn often comorbid with alcohol use disorder (AUD). Nonethleess, the relationship between dermatologic disease and AUD, and the relative contribution of depression and anxiety, are poorly understood. Here, we utilize the National Insittutes of Health All of Us Research Program to investigate the association
-
Practical management of hypertrophic scarring: the mayo clinic experience Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-20 Julia Tomtschik, Nimay Anand, Samyd S. Bustos, Jorys Martinez-Jorge, Saranya P. Wyles
-
Chemical exposures and demographic associations in cutaneous T-cell lymphoma: a large single institution physician validated cohort study Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-18 Ziyou Ren, Lauren P. Chrisman, Yanzhen Pang, Morgan Nguyen, Madeline J. Hooper, Tessa M. LeWitt, Francesca L. Veon, Joan Guitart, Xiaolong A. Zhou
-
Fractional Er:YAG laser versus fractional CO2 laser in the treatment of immature and mature scars: a comparative randomized study Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-18 Mai Abdelraouf Osman, Ahmed Nazmy Kassab
-
Can the mucosal attacks of Behçet’s disease be predicted? Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-18 Selda Pelin Kartal, Gamze Taş-Aygar, Ümmü Gül Erdem, Ali Yalçındağ, Müzeyyen Gönül
The primary objective of this study was to investigate the association between disease activity and serum and salivary procalcitonin (Pct) levels in patients with Behçet’s disease (BD). The study included patients diagnosed with BD and age-matched healthy volunteers (N: 48, N: 32). Serum and salivary Pct levels were quantified using enzyme-linked immunosorbent assay (ELISA) in the laboratories of Diskapi
-
Non-specific language to describe physicians is common across dermatology organization websites Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-13 Jenna Warnimont, Neal Bhatia, Abraham M. Korman
-
Development and initial validation of the Psoriatic Arthritis Screening Questionnaire: a cross-sectional study in Chinese population Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-11 Qin Zou, Mengmeng Li, Yibo Luo, Zerong Chen, Jihui Chen, Yiyi Wang, Dan Hao, Wei Li
-
Exploring the potential role for extended reality in Mohs micrographic surgery Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-09 Anika Pulumati, Yanci A. Algarin, Dana Jaalouk, Melanie Hirsch, Keyvan Nouri
Mohs micrographic surgery (MMS) is a cornerstone of dermatological practice. Virtual reality (VR) and augmented reality (AR) technology, initially used for entertainment, have entered healthcare, offering real-time data overlaying a surgeon’s view. This paper explores potential applications of VR and AR in MMS, emphasizing their advantages and limitations. We aim to identify research gaps to facilitate
-
Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-04 Madeline Deike, Jiancong Wang, Ralph Brinks, Stephan Meller, Lennart Ocker, Falk G. Bechara, Jörg H. W. Distler, Xenofon Baraliakos, David Kiefer, Philipp Sewerin
-
Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alopecia areata: a randomized controlled study Arch. Dermatol. Res. (IF 3.0) Pub Date : 2024-01-03 Rania M. Mogawer, Marwa Mohamed Fawzy, Ahmed Mourad, Heba Ahmed, Maha Nasr, Zeinab Ahmed Nour, Vanessa Hafez
-
Applications of propolis-based materials in wound healing Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-27 Mohamed El-Sakhawy, Ahmed Salama, Hebat-Allah S. Tohamy
-
The role of 755-nm alexandrite picosecond laser in melasma management Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-27 Anika Pulumati, Dana Jaalouk, Yanci A. Algarin, Keyvan Nouri
Abstract Melasma is a skin dyspigmentation condition that disproportionately affects women, particularly those of Latino, Black, and Asian ethnicities, significantly impacting their quality of life. Efforts to identify effective treatment options have led to the exploration of picosecond laser technology which utilizes brief pulse durations to break down pigment while minimizing thermal damage to surrounding
-
Increased ambient outdoor temperatures are associated with increased disease flaring in hidradenitis suppurativa Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-18 Rhea Singh, Ramie Fathy, Bina Kassamali, Megan H. Noe, John S. Barbieri, Avery LaChance, Alexandra P. Charrow
-
Dermatologic conditions in dancers: a statewide survey Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-19 Ryan C. Saal, Joshua F. Edwards, Scott M. Whitlock, Rachel C. Byrd
-
Sebaceous carcinoma: an updated review of pathogenesis, diagnosis, and treatment options Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-19 Caitlin Dowell-Esquivel, Raphael Lee, Robert C. DiCaprio, Keyvan Nouri
Sebaceous carcinoma (SC) is a very rare and aggressive form of skin cancer that arises from the sebaceous glands. SC can occur anywhere on the body, but most commonly affects the head and neck, especially the upper eyelid. SC is the third most common malignancy of the eyelid and has the potential to metastasize and be fatal; therefore, it is vital for dermatologists to remain acquainted with this malignancy
-
Pediatric primary cutaneous anaplastic large-cell lymphoma with associated hypovitaminosis D Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-18 Eleanor Tung-Hahn, Valerie Mogilevskiy, Ellie Black, Michael Morgan, Rebecca Tung
-
The burning truth about light therapy: a retrospective analysis of the MAUDE database on UV phototherapy and photodynamic therapy complications 2013–2023 Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-18
Abstract Introduction Phototherapy and photodynamic therapy (PDT) are ultraviolet light (UV) based therapies for patients with skin diseases, and are sometimes associated with potential adverse events (AE)s, including erythema, pain, pruritus, burns, and photoaging. Methods We investigated UV phototherapy and PDT safety using the United States (US) Food and Drug Administration’s (FDA)’s Manufacturer
-
Sleep and quality of life in kidney transplant recipients with and without non-melanoma skin cancer: a comparative study Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-18 Ellen M. S. Xerfan, Gabriela M. Leandro, Gabriel N. Pires, Monica L. Andersen, Sergio Tufik, Anamaria S. Facina, Jane Tomimori
Non-melanoma skin cancer (NMSC) is prevalent in kidney transplant recipients (KTR), related to the immunosuppressive effects of anti-rejection therapy. Sleep disturbances can alter the immune system and enhance oxidative stress, which may increase the risk of carcinogenesis. This study aimed to analyze the quality of life and sleep in KTR with and without NMSC. Participants answered a set of questionnaires
-
Pre-operative drawings of anticipated closures as a visual tool to align patient and physician expectations for Mohs and reconstructive surgery Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-16 Megan H. Trager, Dawn Queen, Elizabeth Denson, Weijia Fan, Soundos Youssef, Faramarz H. Samie
-
Comments on: racial disparities in dermatology Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-16 Philip R. Cohen, Michelle A. DiMarco, Rachel L. Geller, Lora A. Darrisaw
-
Trends in Mohs surgery fellowship directors Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-16 Kayla D. Mashoudy, Siri Choragudi, Benjamin Schachner, Zachary Zippi, Isabella Rohrabaugh, Keyvan Nouri
-
The impact on quality-of-life following treatment of surgical facial scars with laser-based therapy: a scoping review Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-16
Abstract Post-surgical scarring impacts quality of life (QOL) and is a significant source of morbidity. Existing treatments targeted at improving the appearance and morbidity of scarring include laser-based therapies. Although lasers are frequently used to improve scar appearance, the effects on QOL are unclear. A scoping review was conducted to assess the impact of laser-based therapy for patients
-
Using green background for dermatological images to improve deep learning-based image classification Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-13 Zixi Jiang, Qian Deng, Kai Huang, Rui Ding, Zheng Wu, Weihong Huang, Kehua Guo, Shuang Zhao
-
Risk factors for hospital-based surgical site infections Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-13 Vishnu Harikumar, Noor Anvery, Misha Haq, Rachel E. Christensen, Areeba Ahmed, Eric Koza, Melissa Ma, Victoria Shi, McKenzie A. Dirr, Brandon Worley, Joaquin C. Brieva, Simon S. Yoo, Murad Alam
Surgical site infections (SSIs) contribute to morbidity and are costly to the healthcare system. To identify factors associated with SSIs. Case–control study analyzing the Nationwide Readmission Database (NRD). We identified 45,445 SSIs. Infection rates were higher in those who were obese (BMI ≥ 30) (OR: 1.39, 95% CI 1.28–1.51), tobacco users (OR: 1.08, 95% CI 1.02–1.15), diagnosed with diabetes (OR:
-
Understanding the Medical Dictionary for Regulatory Activities (MedDRA) reporting of herpes simplex virus (HSV) adverse events in atopic dermatitis clinical trials Arch. Dermatol. Res. (IF 3.0) Pub Date : 2023-12-12 Rachel E. Tao, Jessica N. Pixley, Christina L. Kontzias, Steven R. Feldman
Drug efficacy is best evaluated by randomized, controlled, double-blind clinical trials; however, safety is harder to assess. The Medical Dictionary for Regulatory Activities (MedDRA) is used to track and categorize adverse events (AE) during clinical trials. Recent atopic dermatitis (AD) clinical trials were reviewed to illustrate how an understanding of MedDRA may be helpful when evaluating the rates